Belgium· BE-AMP-SAM664044-00
Rytelo 47 mg
A imetelstat product containing imetelstat sodium, registered in Belgium by Geron Netherlands. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Imetelstat is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XX80 (imetelstat), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Imetelstat · ATC L01XX80
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Imetelstat Sodium
- Manufacturer
- Geron Netherlands
- Country
- Belgium (BE)
- ATC code
- L01XX80
- ATC class
- Imetelstat
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imetelstat in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRYTELOGeron Netherlands B.V., Amsterdam
- FinlandRyteloGeron Netherlands B.V.
- IrelandRytelo 47 mg powder for concentrate for solution for infusionGeron Netherlands B.V.
- IcelandRyteloGeron Netherlands B.V.
- PolandRyteloGeron Netherlands B.V.
- SwedenRytelo 47 mg Pulver till koncentrat till infusionsvätska, lösningGeron Netherlands B.V.
- United StatesRYTELOGeron Corporation
- NetherlandsRytelo 188 mg poeder voor concentraat voor oplossing voor infusieGeron Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rytelo
- Liechtenstein · Rytelo
- Norway · Rytelo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8d70b11-6e13-42ec-afad-b1446a0e38c8 GET /v1/drugs/a8d70b11-6e13-42ec-afad-b1446a0e38c8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Rytelo 47 mg",
"name_fr": "Rytelo 47 mg",
"name_nl": "Rytelo 47 mg",
"amp_code": "SAM664044-00",
"strengths": [
"47.0000",
"47.0000"
],
"pack_count": 1,
"substances": [
"Imetelstat Sodium",
"Imetelstat",
"Sodium Carbonate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Imetelstat",
"authorisation_numbers": [
"EU/1/24/1894/001"
]
}See everything about imetelstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.